04:50 PM EDT, 05/13/2025 (MT Newswires) -- John Kiely, Director, on May 12, 2025, sold 50,000 shares in Amneal Pharmaceuticals ( AMRX ) for $379,500. Following the Form 4 filing with the SEC, Kiely has control over a total of 257,433 Class A common shares of the company, with 257,433 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1723128/000162828025025140/xslF345X05/wk-form4_1747168964.xml